Company intelligence / Profile preview

PlumCare RWE

Woodbridge, Connecticut, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

PlumCare RWE does not develop its own therapeutics; it operates commercial real‑world evidence and multi‑omics data platforms (e.g., BeginNGS Greece, FirstSteps newborn genome screening) to enable early diagnosis of ~400 early‑onset actionable genetic conditions and to support pediatric drug discovery and development[1][2][5].

Therapeutic areas: Rare Diseases
Industry: Molecular Diagnostics

Partnerships

Rady Children's Institute for Genomic Medicine (BeginNGS newborn genomic screening program in Greece)[1][2]Lifebit Biotech (federated data platform for BeginNGS Greece)[1][2]Fabric Genomics (Fabric AI platform integrated with FirstSteps newborn genome screening program in Greece)[1][5]National Organization of Public Health (EODY) in Greece, as public‑health partner in BeginNGS Greece[1]

Beyond the preview

Go deeper on PlumCare RWE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PlumCare RWE.

Explore the full profile